Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

25,734 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 7,371
Recruiting: 3,969
Ph III recruiting: 536
Growth YoY: +9.5%
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3,407)

clinicaltrialsPublishedShowing 651–700 of 2,039 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05534438	A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer	recruiting	Phase 2	46	Memorial Sloan Kettering Cancer CenterOTHER	1	Jul 10, 2026	clinicaltrials
NCT06695845	A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors	recruiting	Phase 2	200	Jazz PharmaceuticalsINDUSTRY	3	Jul 10, 2026	clinicaltrials